Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-23 18:00 |
Amoéba annonce l'initiation de la couverture de son titre par Euroland Corporat…
|
French | 335.3 KB | ||
| 2025-01-15 17:45 |
Amoéba announces the publication of the EFSA's final report confirming its posi…
|
English | 358.8 KB | ||
| 2025-01-15 17:45 |
Amoéba annonce la publication du rapport final de l'EFSA confirmant ses conclus…
|
French | 329.3 KB | ||
| 2024-12-17 08:30 |
Amoéba organise une visioconférence ouverte à tous le mercredi 18 décembre 2024…
|
French | 343.3 KB | ||
| 2024-12-16 08:00 |
Amoéba franchit une étape déterminante avec les conclusions positives et défini…
|
French | 357.5 KB | ||
| 2024-12-16 08:00 |
Amoéba reaches a determining milestone with the positive and definitive conclus…
|
English | 380.4 KB | ||
| 2024-12-12 18:00 |
Koppert partners with Amoéba to launch innovative biofungicide solution
|
English | 201.1 KB | ||
| 2024-12-12 18:00 |
Koppert et Amoéba s'associent pour lancer une solution biofongicide innovante
|
French | 182.4 KB | ||
| 2024-11-25 17:45 |
Combating downy mildew in vines: Trials show the effectiveness of the biocontro…
|
English | 233.6 KB | ||
| 2024-11-25 17:45 |
Lutte contre le mildiou en vigne : Des essais montrent l'efficacité du produit …
|
French | 226.6 KB | ||
| 2024-11-21 17:45 |
Amoéba annonce la publication d'un premier article scientifique sur l'efficacit…
|
French | 353.1 KB | ||
| 2024-11-21 17:45 |
Amoéba announces the publication of a first scientific article on the efficacy …
|
English | 357.1 KB | ||
| 2024-10-07 17:45 |
Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2024
|
French | 317.7 KB | ||
| 2024-10-07 17:45 |
Amoéba: Publication of the half-year financial report at 30 June 2024
|
English | 353.4 KB | ||
| 2024-10-03 17:45 |
Amoéba: the first half of 2024 confirms the strategic pivot towards an industri…
|
English | 414.6 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
